CHOLINERGIC MATURATION AND SCH-23390-INDUCED CATALEPSY IN THE MALE-RAT PUP

被引：24

作者：

FITZGERALD, LW

HANNIGAN, JH

机构：

[1] SUNY ALBANY,CTR BEHAV TERATOL,SS-112,1400 WASHINGTON AVE,ALBANY,NY 12222

[2] SUNY ALBANY,DEPT PSYCHOL,ALBANY,NY 12222

来源：

DEVELOPMENTAL BRAIN RESEARCH | 1989年 / 47卷 / 01期

关键词：

D O I：

10.1016/0165-3806(89)90118-1

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：147 / 150

页数：4

共 14 条

[1]

ARBILLA S, 1987, NEUROTRANSMITTER INT, P111

[2] RELATIVE DOPAMINE D1 AND D2 RECEPTOR AFFINITY AND EFFICACY DETERMINE WHETHER DOPAMINE AGONISTS INDUCE HYPERACTIVITY OR ORAL STEREOTYPY IN RATS [J].

ARNT, J ;

BOGESO, KP ;

HYTTEL, J ;

MEIER, E .

PHARMACOLOGY & TOXICOLOGY, 1988, 62 (03) :121-130

[3] POSTNATAL-DEVELOPMENT OF A CHOLINERGIC INFLUENCE ON NEUROLEPTIC-INDUCED CATALEPSY [J].

BURT, DK ;

HUNGERFORD, SM ;

CROWNER, ML ;

BAEZ, LA .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 16 (04) :533-540

[4] SCOPOLAMINE MODULATES APOMORPHINE-INDUCED BEHAVIOR IN RATS TREATED WITH HALOPERIDOL OR SCH-23390 [J].

BUTKERAIT, P ;

FRIEDMAN, E .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (02) :269-272

[5] ONTOGENESIS OF DOPAMINERGIC-CHOLINERGIC INTERACTIONS IN RAT STRIATUM - NEUROCHEMICAL STUDY [J].

COYLE, JT ;

CAMPOCHIARO, P .

JOURNAL OF NEUROCHEMISTRY, 1976, 27 (03) :673-678

[6] SPECIFIC-INHIBITION OF DOPAMINE-D-1-MEDIATED CYCLIC-AMP FORMATION BY DOPAMINE-D-2, MUSCARINIC CHOLINERGIC, AND OPIATE RECEPTOR STIMULATION IN RAT STRIATAL SLICES [J].

KELLY, E ;

NAHORSKI, SR .

JOURNAL OF NEUROCHEMISTRY, 1986, 47 (05) :1512-1516

[7] D-1 AND D-2 RECEPTOR BLOCKADE HAVE ADDITIVE CATALEPTIC EFFECTS IN MICE, BUT RECEPTOR EFFECTS MAY INTERACT IN OPPOSITE WAYS [J].

KLEMM, WR ;

BLOCK, H .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (02) :223-229

[8] HALOPERIDOL DIFFERENTIALLY POTENTIATES TONIC IMMOBILITY, THE DORSAL IMMOBILITY RESPONSE, AND CATALEPSY IN THE DEVELOPING RAT [J].

MEYER, ME ;

SMITH, RL ;

VANHARTESVELDT, C .

DEVELOPMENTAL PSYCHOBIOLOGY, 1984, 17 (04) :383-389

[9]

MURRIN LC, 1986, BIOCHEM PHARMACOL, V35, P1159, DOI 10.1016/0006-2952(86)90154-1

[10]

SCATTON B, 1986, EUR J PHARMACOL, V129, P359

← 1 2 →